Indy Hematology Review
Avatar

Chronic Myelomonocytic Leukemia: Define, Diagnosis, Prognostications and Treatment

By Indy Hematology Review FEATURING Ayalew Tefferi
By Indy Hematology Review FEATURING Ayalew Tefferi
309 views
April 12, 2018
Comments 1
Login to view comments. Click here to Login

Featured Video

12:58
Incyte

Spleen Volume Reduction and Long-Term Survival in Myelofibrosis: Whe…

Feat. R. Mesa

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Related Videos

20:10

ASH 2024 Summary: CMML Highlights

2024 ASH Annual Meeting Insights Hub

D. Tremblay

228 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

605 views
17:45

Clonal Hematopoiesis: CHIP & CCUS Definition and Clinical Implicatio…

Shyam Patel

48 views
07:49

A Case of CMML With Recurrent Skin Involvement

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Arslan Davulcu

23 views
17:04

New

Indy Hematology Review 2025: CMML - Classification, Diagnosis, Prese…

Indy Hematology Review 2025

A. Tefferi

06:46

ASH 2023 Insights: "Guadecitabine in Higher-Risk MDS and CMML Under …

Insights from 2023 ASH Annual Meeting

S. Urrutia

68 views
10:38

ASH 2023 Insights: "Venetoclax Improves Response Rates But Not Survi…

Insights from 2023 ASH Annual Meeting

D. Tremblay

37 views
11:20

SOHO 2021 Update on CMML Overview of the Most Recent Data

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

G. Montalban-Bravo

63 views
15:33

2020 SOHO Updates on Oral HMAs in MDS: Can FDA-Approved Decitabine/C…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Garcia-Manero

168 views
10:43

MD Anderson Immune Checkpoint Based Approaches in AML & MDS: Which C…

Naval Daver

151 views
21:24

2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benefit t…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Tyner

51 views
12:19

How to Calculate Risk in MDS Patients?

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

98 views
22:02

TGF Beta Pathway Inhibition in MDS: Luspatercept Significantly Decre…

University of Miami's 2nd Biennial Miami Leukemia Symposium

A. Verma

119 views
18:24

In Transplant-Eligible Patients With Higher-Risk MDS, Hypomethylatin…

Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

A. Mishra

189 views
14:59

In Transplant-Eligible Patients With Higher-Risk MDS, Hypomethylatin…

Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

R. Komrokji

185 views
14:36

Frontline Therapies in MDS: Leveling Lower-risk MDS

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

43 views
20:06

2020 Update on Splicing in MDS: How Can We Target Spliceosome-Mutant…

University of Miami's 2nd Biennial Miami Leukemia Symposium

T. Graubert

16 views
20:00

MDS/MPN Overlap Through Interactive Case Based Discussion: Overview …

Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

A. Kuykendall

49 views
26:41

2019 ASH Review on MDS: Luspatercept Under FDA Review, Novel Oral HM…

Cleveland Clinic's 20th Annual ASH Review

H. Carraway

33 views
05:28

Frontline Therapies in MDS: Hampering Higher-risk MDS

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

22 views
AUTOPLAY